C4 Therapeutics, Inc
NASDAQ:CCCC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C4 Therapeutics, Inc
NASDAQ:CCCC
|
US |
|
S
|
Surteco Group SE
F:SUR
|
DE |
|
E
|
Equifax Inc
DUS:EFX
|
US |
|
S
|
SBM Offshore NV
XHAM:IHCB
|
NL |
|
L
|
Linde PLC
XHAN:LIN
|
UK |
|
D
|
Deutsche Boerse AG
F:63DA
|
DE |
|
Larsen & Toubro Ltd
NSE:LT
|
IN |
|
P
|
PostNL NV
DUS:TNTC
|
NL |
|
T
|
TUI AG
DUS:TUI1
|
DE |
|
A
|
Abbott Laboratories
F:ABL
|
US |
|
China Resources Beer Holdings Co Ltd
HKEX:291
|
HK |
|
S
|
Smart Equity AG
XHAM:SE3
|
DE |
|
Fathom Holdings Inc
NASDAQ:FTHM
|
US |
|
P
|
Public Storage
F:PUP
|
US |
|
G
|
Gen Digital Inc
XMUN:SYM
|
US |
|
Hermes International SCA
PAR:RMS
|
FR |
|
Figeac Aero SARL
F:1F1
|
FR |
Bankruptcy Probability
C4 Therapeutics, Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
C4 Therapeutics, Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
C4 Therapeutics, Inc
NASDAQ:CCCC
|
394.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
510.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
251.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
211.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
140.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
99.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
88.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
54.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
C4 Therapeutics, Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, C4 Therapeutics, Inc has no debt.
You can find a full breakdown on its Balance Sheet.
